At the conclusion of this course, participants will be able to:

Female Pelvic Medicine:

1. Describe treatment options for common female urologic conditions.
2. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB).

Bladder Cancer:

1. Explain the risk-stratified clinical framework for the management of non-metastatic muscle-invasive and non-muscle invasive urothelial bladder cancer.
2. Identify treatment options for non-metastatic muscle-invasive bladder cancer including chemotherapy, cystectomy, urinary diversion, lymphadenectomy, and various bladder preserving options.
3. Discuss the diagnosis of muscle-invasive bladder cancer and the use of urine markers in addition to variant histologies, resection, intravesical therapy, BCG therapy, cystectomy, enhanced cystoscopy and patient follow-up. 
4. Integrate AUA guidelines into clinical practice.

Pediatric Urology:

1. Diagnose, manage and provide consultation for complications such as hydronephrosis and bladder exstrophy. 
2. Diagnose and provide cost-effective management of common pediatric urology problems including Ureterocele and Ectopic Ureter.
3. Outline evaluation, medical and surgical management, of common postnatal obstruction of the urinary tract, including UPJ obstruction, UVJ obstruction and posterior urethral valves.

Endourology and Urolithiasis:

1. Interpret metabolic evaluations for patients with kidney stones according to the published guidelines.
2. Discuss the use of medications in the prevention of kidney stones, including side effects.
3. Outline dietary considerations used for the prevention of stones.
4. Explain the recommended preoperative evaluation for patients considering kidney stone surgery (including laboratory studies and imaging).
5. Describe a surgical treatment plan for patients with kidney and/or ureteral stones in adult and pediatric patients, including surgical approach and discussion of complications.

BPH/LUTS:

1. Explain the role of diagnostic testing in making the accurate diagnosis of male LUTS using the new BPH Guidelines.
2. Identify common pathophysiological etiologies of voiding and sexual health.
3. Define the safety and efficacy of new minimally invasive options for BPH including prostatic urethral lift and convective water vapor therapy and surgical options such as Aquablation and electrosurgical and laser therapies.
4. Describe the impact of current therapeutic strategies on both voiding and sexual dysfunction.

Reconstruction/Trauma:

1. Differentiate among the variety of etiologies of ureteral strictures.
2. Describe and summarize radio-graphic testing to accurately define the stricture.
3. Identify key steps in surgical techniques to provide for best possible surgical results.
4. Describe guidelines-driven, evidence-based treatment algorithms for injuries to the kidney, ureter, bladder, urethra and external genitalia.
5. Distinguish between injuries that require non-operative surveillance, immediate surgery, and adjunctive interventions such as angio-embolization or endourologic management.

Testicular Cancer:

1. Describe treatment options for patients with clinical stages I, IIA, and IIB seminoma and nonseminomatous (NSGCT) germ cell tumors and utilize the low-stage testis cancer treatment algorithm.